Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Role of Autoreactive B Cells in Rheumatoid Arthritis

Catherine Kolonko  |  Issue: September 2019  |  September 17, 2019

What They Found

Results showed the RA-CCPpos B cells differentially express IL-15α and genes related to protein citrullination, as well as signaling of cyclic adenosine monophosphate (cAMP), which regulates several immune pathways in RA. This indicates that, unlike RA-CCPneg B cells, RA-CCPpos B cells play a potential role in protein citrullination and inflammation.

Other findings were consistent with previous studies of B cell pathways related to excess production of tumor necrosis factor (TNF), a protein associated with inflammation in RA patients, Dr. Varadarajan says. More surprising was that the receptor for the cytokine IL-15 was present specifically only in the autoreactive B cells from patients with RA.

Designua / shutterstock.com

Designua / shutterstock.com

“They were not on either the healthy B cells or the B cells that were not autoreactive in these RA patients,” Dr. Varadarajan says.

Researchers also discovered new information about amphiregulin, Dr. Varadarajan says. For years EGF ligands have been well chronicled for their role in the development of cancer and RA. “One of the surprising things that came out of our study was that a particular family member, called amphiregulin, was present in the autoreactive B cells” from the donor RA patients but was not present in the proteins from healthy donors, he says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

To further investigate the role of amphiregulin in autoreactive B cells, the team conducted validation studies that indicated the concentration of the protein was higher in blood and the synovial fluid of CCP-positive patients with RA, he says. These elevations spur the proliferation of an aggressive pheno­type of fibroblast-like synoviocytes.

“That also confirmed the importance of this particular protein that we found in these autoreactive B cells. Prior to this, we are not aware of any study that shows that B cells are even capable of making [amphiregulin],” Dr. Varadarajan says.

Learning About the Pathways

The amphiregulin discovery is significant because the protein appears to work in concert with anti-citrullinated protein antibodies to cause increased differentiation of multi-nucleated osteoclasts, cells responsible for bone erosion.

“That’s the finding that links everything together,” Dr. Varadarajan says. “The B cells can produce these amphiregulins, and B cells also make these autoantibodies.

“If we take a step back and think globally, we’ve produced a map of what is different between autoreactive B cells and B cells from healthy donors,” he says.

The generated data lay the groundwork for other researchers who want to further investigate B cell pathways in RA and other autoimmune disorders, Dr. Mahendra says.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:amphiregulinautoreactive B cells

Related Articles

    Characterization of Autoreactive B Cells in Patients with SLE & RA

    May 6, 2019

    Antibody-secreting cells are important for the pathophysiology of SLE and RA, but researchers have been unable to determine how these cells are activated. A new technique is able to distinguish between naïve autoreactive B cells and established antibody secreting cells…

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    Autoreactive Germinal Centers: A Single Autoreactive B Cell Clone Can Drive Autoimmunity

    October 16, 2017

    A study in mice provides insight into the maturation of the self-reactive B cell response, contextualizing the epitope spreading observed in autoimmune disease. Researchers found that clonal expansion of wild type B cells in autoreactive germinal centers appeared to be at the heart of epitope spreading and the consequent autoimmune response…

    Alpha Tauri 3D Graphics / shutterstock.com

    Study Elucidates Potential Flare Pathways in Rheumatoid Arthritis

    December 14, 2020

    Research in The New England Journal of Medicine has opened new avenues for exploring the pathophysiology of disease flares in rheumatoid arthritis.1 Through longitudinal genomic analysis, researchers have identified a naive B cell signature prior to rheumatoid arthritis flares, as well as a type of mesenchymal cell, that may play an important role in flare…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences